SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (3879)9/24/1997 5:11:00 PM
From: Nanny   of 3991
 
<<<Carlton has been accused in the Wall Street Jour (sic) write up 1 year ago of playing both ends of the stick: The SEC (I believe) is accusing him of recommending Presstek to his letter readers while his sons managing the Cabot Fund either sold Presstek on the way up and/or sold it short.>>>

Excuse me, but all of the above assumptions are wrong! Mr. Lutts neither sold Presstek shares nor shorted Presstek shares! Any selling was for portfolio balancing ONLY! If a stock is performing SO WELL that it becomes too large a part of your portfolio then prudent management would reduce positions!!! Excuse me for butting in here but Presstek and Carlton Lutts have had their positions misrepresented too many times in the past to not correct any misunderstandings. I hope you understand.

BTW, Cabot reiterated his "buy" recommendation on Vivus yesterday. I am long VVUS also.

Regards,

Nanny
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext